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S1 Descriptive statistics of the gene regulatory network structure
In this study, we collected transcription factor (TF) and microRNA (miRNA) regulations to construct global human gene regulatory networks (GRN) from predicted and experimentally validated data, respectively. This predicted GRN consists of 107 TFs, 1,851 mature miRNAs, 18,705 target genes, and 825,659 regulations among these molecules. The experimentally validated network consists of 10,046 regulations among 597 TFs, 497 miRNAs, and 2581 target genes. Detailed information regarding network structure for these two GRNs is depicted in Table   S1 . 
S2 Reliability of the gene regulatory network
In the predicted GRN, we observed that in-degree, i.e. regulations to targets, showed scale-free distribution, but out-degree, i.e. regulations from regulators, did not ( Figure S1A ). To further confirm this, we investigated the degree distribution of the experimentally validated GRN.
Interestingly, both the in-degree and out-degree of the experimentally validated GRN showed scale-free distribution ( Figure S1B ). These observations might uncover the high false positive rate of this predicted GRN. However, the experimentally validated GRN could be subject to publication bias, i.e. regulators studied more could possess more targets. Indeed, in the experimentally validated GRN, the TF and miRNA out-degree are both significantly and highly correlated with the number of publications (Spearman′s ρ, TF: 0.49, P < 2.2×10-16; miRNA:
0.68, P < 2.2×10-16); this positive correlation was observed only for miRNA in the predicted GRN (Spearman′s ρ, TF: 0.18, P = 0.06; miRNA: 0.36, P = 6.7 × 10-13) ( Table S2 ). The information regarding the publications was obtained from National Center for Biotechnology Information (NCBI) database. These observations implied that the predicted GRN might possess a high false positive rate, but the experimentally validated GRN might be potentially biased by the number of publications.
Accordingly, we considered the expression correlation between regulators and target genes to filter out potential false positive regulations and publication bias. We incorporated the mRNA and miRNA expression profiles of seven cancer types from The Cancer Genome Atlas (TCGA).
We then mapped the expression correlations of each regulation to the predicted GRN to contrast the correlated GRN for each cancer type. We observed that the highest out-degree of the correlated GRN can be controlled by around 1,000 when only the top 1%, 5%, or 10% highly correlated regulations are used for each cancer type ( Figure S2 ). To note, the highest out-degree in the experimentally validated GRN is 648. Moreover, the averaged R 2 of out-degree distribution for the top 1%, 5%, and 10% highly correlated GRN was increased to around 0.5 (Normal: 1%: 0.48, 5%: 0.5, 10%: 0.45; Tumor: 1%: 0.51, 5%: 0.48, 10%: 0.49) ( Figure S1 ).
Notably, the R 2 of out-degree distribution for the predicted GRN is 0.17. Interestingly, the publication bias could also be reduced by incorporating expression correlations between regulators and targets the predicted GRN (Table S2) . The above results suggested that the application of the expression correlations between regulators and targets may be able to reduce the false positive rate of the predicted GRN, control the out-degree distribution as scale-free, and reduce publication bias. Figure S1 : Regulation degree distribution of the GRNs
The degree distributions of (A) predicted (B) experimentally validated GRN. Out-degree:
regulations from regulators; In-degree: regulations to targets. The out-degree distribution profile of the top 1%, 5%, and 10% highly correlated GRN for each cancer type. The log10 frequency of regulators is shown as a function of the log10 out-degree of regulators. The R 2 of the out-degree distribution is labeled on the top of each sub-chart. Figure S3A) . Notably, the cancer-associated genes used in this study are required to be associated with cancer through mutation [1] [2] [3] . Therefore, this result proposes that these noncancer-associated TFs with differential regulatory activity might be involved in cancer development through the regulation of cancer-associated targets rather than mutations. 
S4 Identification of STAT1-regulated functional modules
To discover the STAT1-regulated downstream functional modules, we collected STAT1 target genes that are significantly 1) positively co-expressed with STAT1 and 2) up-regulated in tumor samples for each cancer type. Through these two conditions, we obtained those functional modules potentially activated by STAT1 in a tumor. The significantly positive co-expression was defined as the absolute standard score ≥ 2.5 (the corresponding significance is P < 0.01). The significant up-regulation in tumor is defined as edgeR P < 0.05, adjusted by the Benjamini and Hochberg multiple testing procedures 4 .
Next, we performed functional enrichment analysis using Gene Ontology (GO) 5 annotations to determine the enriched functions in which these selected target genes are involved. Of note,
we conducted the functional enrichment analysis in two ways, conventional and network-wise 6, 7 .
With the conventional way, the overrepresentation of selected STAT1 target genes defines the significance of STAT1-regulated functions. On the other hand, the network-wise enrichment analysis evaluates the significance of STAT1-regulated functions through the overrepresentation of functional protein-protein interactions (PPIs) among selected STAT1 targets. The PPIs were obtained from the Protein Interaction Network Analysis (PINA) v2 8, 9 . Notably, the functional PPIs are PPIs formed by the two proteins involved in the same functions. Moreover, because we applied network-wise enrichment analysis, we further stipulated that the selected STAT1 target genes must be collected in the PPI network in the following analyses. The significance of each function is determined by the P-value produced from Hypergeometric test. For the conventional way, the hypergeometric distribution is:
where X denotes the evaluated function. N represents the number of GO annotated genes in the used expression profiles, as well as in PINA PPI network, while m indicates that in the selected STAT1 target genes. n represents the number of genes with the evaluated GO annotations in the used expression profiles as well as in PINA PPI network, while k indicates that in the selected STAT1 target genes. Thus, this formula calculated the probability of the evaluated GO annotations that contains k selected STAT1 target genes. For the network-wise way, we applied a modified hypergeometric distribution as below:
e is the abbreviation of the functional PPIs. Each symbol represents the same meaning as the previous one in the conventional hypergeometric distribution, but the counting objects are changed from genes to functional PPIs. All the P-values are adjusted by the Benjamini and
Hochberg multiple testing procedures to control the false discovery rate (FDR).
For each GO annotations, the two P-values produced by the conventional and network-wise method are further combined as a summarized P-value by Fisher′s method 10 . For each cancer type, a GO annotation is provided with a summarized P-value. We further combined these summarized P-values of a GO annotation as a combined P-value across the seven studied cancer types by Fisher′s method again. That is, we used the combined P-value to assess the enrichment consistency of the GO annotation across the studied seven cancer types. Furthermore, we utilized these combined P-values to rank the GO annotations in which the selected STAT1 target genes are involved. Finally, we considered the top 20 significant enriched GO annotations as potential STAT1-regulated downstream functions.
S5 mRNA and miRNA expression profiles
The mRNA and miRNA expression profiles of seven cancer types in The Cancer Genome Atlas Table S3 . 
S6 List of the drugs differentially regulated STAT1 expression
Supplementary file S1
